Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failure
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 30 (1) , 27-35
- https://doi.org/10.1016/0168-8227(95)01137-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- PHYSIOLOGICAL BASIS OF THE EFFECTIVENESS OF COMBINED INSULIN-TOLBUTAMIDE THERAPY IN STABLE DIABETES*Annals of the New York Academy of Sciences, 2006
- Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureasDiabetes Research and Clinical Practice, 1989
- The Combined Use of Insulin and Sulfonylurea Therapy in Patients with Non-Insulin Dependent Diabetes MellitusHormone and Metabolic Research, 1989
- Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trialJAMA, 1987
- Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitusArchives of internal medicine (1960), 1986
- Kombinierte Behandlung von Typ-II-Diabetikern mit Insulin und Glibenclamid nach Tablettensekundärversagen: Doppelblinde, Insulin-Placebo-kontrollierte Cross-over-Studie*Deutsche Medizinische Wochenschrift (1946), 1985
- The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetesActa Endocrinologica, 1984
- The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucoseMetabolism, 1983
- Kombination von Insulin und Sulfonylharnstoffen bei der Therapie des Diabetes mellitus vom Erwachsenen-TypDeutsche Medizinische Wochenschrift (1946), 1982
- Assessment of insulin resistance with the insulin suppression test and the euglycemic clampDiabetes, 1981